Cravath, Kirkland Guide $40 Billion Tylenol-Maker Kenvue Buy

Nov. 3, 2025, 5:00 PM UTC

Big Law firms including Cravath and Kirkland led Kimberly-Clark Corp.'s agreement to buy Tylenol-maker Kenvue Inc, in a deal worth around $40 billion.

Cravath, Swaine & Moore’s M&A team guiding Kenvue was led by co-chairs of the firm’s global mergers and acquisitions Practice Robert I. Townsend III and George F. Schoen; and corporate partners Michael E. Mariani and Jin-Kyu Baek. Townsend and Schoen worked on the separation of Johnson & Johnson’s consumer health business beginning in 2021.

Kimberly-Clark was guided by Kirkland & Ellis. Its team included Kim Hicks, who is a founding partner of the firm’s Austin office; ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.